临床特拉万辛失败在持久性甲素耐药黄金葡萄球菌的细菌病
Kevin T Dao1, Carlos D'Assumpcao2, Rupam Sharma1
1Internal Medicine, UCLA-Kern Medical, Bakersfield, USA.
Cureus
|March 28, 2025
概括
泰拉万辛是一种来自万科米辛的抗生素,可能无法治疗持久性甲素耐药金黄色葡萄球菌 (MRSA) 细菌病. 本案例研究探讨了这种治疗失败背后的原因,并提供了对抗生素耐药性挑战的见解.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泰拉万是一种脂糖类抗生素,是万科米的半合成衍生物.
- 它主要用于治疗严重的格拉姆阳性细菌感染,包括由耐甲基黄金葡萄球菌 (MRSA) 引起的.
- 尽管它有效,但抗生素耐药性和治疗失败可能会发生.
研究的目的:
- 报告特拉万辛失效的临床病例.
- 为了调查患有持续性MRSA细菌血症的患者治疗失败的根本原因.
主要方法:
- 病例报告详细介绍了一名患有MRSA细菌病的患者.
- 对治疗反应的临床和微生物学评估.
- 对可能导致特拉万辛失效的潜在因素的分析.
主要成果:
- 泰拉万辛治疗未能消除持续的MRSA细菌血症.
- 确定导致观察到的临床失败的特定因素.
结论:
- 泰拉万辛可能无法治疗某些持续性MRSA感染.
- 了解失败的机制对于优化抗生素治疗至关重要.
相关概念视频
Endocarditis III: Medical Management
360
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
360
Antimicrobial Effectiveness
2.3K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Staphylococcal Skin Infections
143
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90


